Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Annales De Biologie Clinique|March 14, 2025
Placenta percreta management in a patient with a severe congenital hypofibrinogenaemiaJordan Wimmer, Laurent Sattler, Agathe Herb, et al.
Life (Basel, Switzerland)|November 27, 2025
Diagnostic Reassessment of a Historical Case of Atypical Heparin-Induced Thrombocytopenia: Between Spontaneous Heparin-Induced Thrombocytopenia and a Vaccine-Induced Immune Thrombotic Thrombocytopenia-Like SyndromeJordan Wimmer, Solène Kirscher, Manon Dolt, et al.
Digestive Diseases and Sciences|April 7, 2005
Circulating cell-derived microparticles in Crohn's diseasePatrick Chamouard, Dominique Desprez, Bénédicte Hugel, et al.
The Canadian Journal of Cardiology|May 4, 2015
Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factorThibault Caspar, Laurence Jesel, Dominique Desprez, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2026
The p.T216R mutation of the thromboxane A2 receptor disrupts platelet function by selectively altering the G12/23 signaling pathwayKevin Denis, Véronique Heim, Mathieu Fiore, et al.
Therapeutic Advances in Hematology|January 28, 2025
Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in FranceHervé Chambost, Yohann Repessé, Fabienne Genre-Volot, et al.
Thrombosis Research|May 4, 2020
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiencyLucia Rugeri, Christophe Martinaud, Philippe Beurrier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 7, 2021
Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical proceduresDominique Desprez, Nicolas Drillaud, Claire Flaujac, et al.
British Journal of Haematology|August 16, 2019
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohortSéverine Bouttefroy, Sandrine Meunier, Vanessa Milien, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2020
Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing studyJenny Goudemand, Françoise Bridey, Ségolène Claeyssens, et al.
Pageof 4